Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 87 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

BRIEF COMMUNICATION

Sodium-glucose cotransporter-2 inhibition and the insulin: Glucagon ratio: Unexplored dimensions

Kalra Sanjay, Gupta Yashdeep, Patil Shiva

Year : 2015| Volume: 19| Issue : 3 | Page no: 426-429

   This article has been cited by
 
1 Sodium–glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice
Shinji Tanaka,Yuki Sugiura,Hisako Saito,Mai Sugahara,Yoshiki Higashijima,Junna Yamaguchi,Reiko Inagi,Makoto Suematsu,Masaomi Nangaku,Tetsuhiro Tanaka
Kidney International. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement
Sanjay Kalra,Sujoy Ghosh,AH Aamir,Md. Tofail Ahmed,MohammodFeroz Amin,Sarita Bajaj,ManashP Baruah,Uditha Bulugahapitiya,AK Das,Mimi Giri,Sonali Gunatilake,SaeedA Mahar,Md. Faruque Pathan,NazmulKabir Qureshi,SAbbas Raza,Rakesh Sahay,Santosh Shakya,Dina Shreshta,Noel Somasundaram,Manilka Sumanatilleke,AG Unnikrishnan,AchiniMadushani Wijesinghe
Indian Journal of Endocrinology and Metabolism. 2017; 21(1): 210
[Pubmed]  [Google Scholar] [DOI]
3 Dapagliflozin for the treatment of type 1 diabetes mellitus
Kalliopi Pafili,Efstratios Maltezos,Nikolaos Papanas
Expert Opinion on Investigational Drugs. 2017; 26(7): 873
[Pubmed]  [Google Scholar] [DOI]
4 Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives
Hongyu Qiu,Aleksandra Novikov,Volker Vallon
Diabetes/Metabolism Research and Reviews. 2017; : e2886
[Pubmed]  [Google Scholar] [DOI]
5 Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus
Hala Ahmadieh,Sami Azar
Diabetes Technology & Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
D Dutta,S Kalra,M Sharma
Journal of Postgraduate Medicine. 2017; 63(2): 114
[Pubmed]  [Google Scholar] [DOI]
7 DIABETIC KETOACIDOSIS IN A PATIENT WITH TYPE 2 DIABETES ON CANAGLIFLOZIN AND DEXAMETHASONE
Lisa D. Alexander,Catherine Yu
AACE Clinical Case Reports. 2017; 3(4): e331
[Pubmed]  [Google Scholar] [DOI]
8 Sodium-glucose cotransporter-2 inhibitors: Moving beyond the glycemic treatment goal
Vishal Gupta,William Canovatchel,BN Lokesh,Ravi Santani,Nishant Garodia
Indian Journal of Endocrinology and Metabolism. 2017; 21(6): 909
[Pubmed]  [Google Scholar] [DOI]
9 The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
Sanjay Kalra,Yashdeep Gupta
Diabetes Therapy. 2016;
[Pubmed]  [Google Scholar] [DOI]
10 Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
Heidi Storgaard,Jonatan I. Bagger,Filip K. Knop,Tina Vilsbøll,Jørgen Rungby
Basic & Clinical Pharmacology & Toxicology. 2016; 118(2): 168
[Pubmed]  [Google Scholar] [DOI]
11 Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review
AwadheshKumar Singh,Ritu Singh
Indian Journal of Endocrinology and Metabolism. 2016; 20(1): 32
[Pubmed]  [Google Scholar] [DOI]
12 Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
Sanjay Kalra,Arpit Jain,Jignesh Ved,AG Unnikrishnan
Indian Journal of Endocrinology and Metabolism. 2016; 20(5): 725
[Pubmed]  [Google Scholar] [DOI]
13 Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight
AwadheshKumar Singh
Indian Journal of Endocrinology and Metabolism. 2015; 19(6): 722
[Pubmed]  [Google Scholar] [DOI]

 

Read this article